WRKY31 Antibody

What is WRKY31 and why is it important for plant stress research?

WRKY31 belongs to the WRKY transcription factor family, one of the largest transcription factor families in plants. These proteins play crucial regulatory roles in plant responses to various stresses. TaWRKY31 in wheat participates in drought stress responses, while OsWRKY31 in rice (also called OsWRKY55) is a positive regulator of resistance against Magnaporthe oryzae (rice blast fungus) .

WRKY31 contains a characteristic WRKYGQK amino acid sequence and a C2H2-type zinc finger structure, typical of group II WRKY proteins . It functions as a nuclear-localized transcription factor with activation activity at its N-terminus . Research using these proteins has revealed important mechanisms of plant stress adaptation, making antibodies against WRKY31 valuable tools for investigating stress response pathways.

How can I determine the specificity of a WRKY31 antibody?

Determining antibody specificity is critical due to the high conservation within the WRKY family. Use these approaches:

• Genetic validation: Test antibodies against WRKY31-silenced plants (such as BSMV:WRKY31-1as or BSMV:WRKY31-2as silenced wheat lines) as negative controls . Also test against WRKY31-overexpressing plants (like the Ubi:fW31h lines in rice) as positive controls .

• Western blot analysis: Run protein extracts from:

  • Wild-type plants

  • WRKY31 knockout/silenced plants

  • Plants overexpressing WRKY31

  • Recombinant WRKY31 protein (positive control)

• Cross-reactivity assessment: Test against closely related WRKY proteins. The phylogenetic analysis shows TaWRKY31 has high sequence similarity with HvWRKY57 in barley and AtWRKY57 in Arabidopsis .

• Immunoprecipitation-mass spectrometry: Perform IP with the WRKY31 antibody followed by mass spectrometry to confirm it specifically pulls down WRKY31 and not other WRKY proteins.

• Dot blot analysis: Test antibody against synthetic peptides representing different regions of WRKY31 and other WRKY family members to map epitope specificity.

What are the optimal methods for detecting WRKY31 protein expression in different plant tissues?

For effective detection of WRKY31 across tissues, consider these methodological approaches:

• Western blotting protocol optimization:

  • Use nuclear extraction protocols since WRKY31 is nucleus-localized

  • Include phosphatase inhibitors to preserve phosphorylation states

  • Optimize protein extraction buffers to account for tissue-specific interfering compounds

  • Consider tissue-specific expression patterns (TaWRKY31 shows highest expression in glume and lower levels in palea)

• Immunohistochemistry/Immunofluorescence:

  • Optimize fixation conditions (typically 4% paraformaldehyde)

  • Use antigen retrieval techniques if necessary

  • Include nuclear stain (like DAPI) to confirm nuclear localization

  • Compare with GFP fusion localization data for validation

• ELISA-based quantification:

  • Develop sandwich ELISA using purified WRKY31 antibodies

  • Generate standard curves with recombinant WRKY31

  • Useful for high-throughput analysis across multiple tissues or conditions

• Flow cytometry:

  • For single-cell analysis of WRKY31 expression

  • Particularly useful for studying heterogeneity within tissues

When analyzing results, remember that WRKY31 expression is stress-responsive, with TaWRKY31 significantly upregulated under PEG-6000 and NaCl stresses at 48 hours (2.49 and 5.77-fold increases, respectively) .

How can I optimize protein extraction for WRKY31 detection?

Effective protein extraction is crucial for reliable WRKY31 detection:

• Nuclear protein extraction protocol:

  • Since WRKY31 is nuclear-localized , use nuclear extraction methods

  • Include nuclei isolation step with appropriate buffers (e.g., containing Triton X-100)

  • Use high-salt extraction buffer for efficient extraction of DNA-binding proteins

• Buffer components:

  • Include protease inhibitor cocktail to prevent degradation

  • Add phosphatase inhibitors (sodium fluoride, sodium orthovanadate) to preserve phosphorylation states, particularly important as OsWRKY31 is known to be phosphorylated at Ser6 and Ser101

  • Include reducing agents (DTT or β-mercaptoethanol) to maintain protein structure

  • Consider detergents like NP-40 or CHAPS for membrane disruption

• Tissue-specific considerations:

  • For tissues with high phenolic compounds, add PVPP or PVP to the extraction buffer

  • For tissues with high starch content, perform additional centrifugation steps

  • Consider that TaWRKY31 shows tissue-specific expression patterns, with highest expression in glume tissues

• Extraction conditions:

  • Maintain cold temperatures throughout extraction (4°C)

  • Optimize sonication or homogenization parameters

  • Consider cross-linking for protein-protein interaction studies

• Quality control:

  • Verify nuclear extraction efficiency with nuclear markers

  • Check protein integrity by Coomassie staining before immunoblotting

How can WRKY31 antibodies be used to investigate phosphorylation status?

WRKY31 phosphorylation significantly impacts its function, as demonstrated for OsWRKY31 where phosphorylation enhances its DNA-binding and activation of disease resistance . To investigate phosphorylation:

• Phospho-specific antibodies development:

  • Generate antibodies against phosphorylated Ser6 and Ser101 of OsWRKY31

  • Use synthetic phosphopeptides containing these sites for immunization

  • Purify antibodies against phosphorylated and non-phosphorylated peptides

• Phosphorylation detection methods:

  • Western blot using phospho-specific antibodies

  • Phos-tag SDS-PAGE to separate phosphorylated from non-phosphorylated forms

  • IP with general WRKY31 antibody followed by phospho-specific antibody detection

  • Lambda phosphatase treatment as control to confirm phosphorylation specificity

• Functional analysis:

  • Compare phosphorylation status under different stress conditions

  • Correlate with DNA-binding activity using ChIP or EMSA

  • Compare with phosphomimetic (W31 S6DS101D) and phosphonull (W31 S6AS101A) variants

• Kinase-substrate relationship analysis:

  • Investigate MAPK-mediated phosphorylation using OsMPK3, OsMPK4, or OsMKK10-2-activated OsMPK6

  • In vitro kinase assays with recombinant proteins

  • Co-IP to detect association with relevant kinases

Research shows that phosphomimetic OsWRKY31 (W31 DD) plants display enhanced resistance to M. oryzae compared to phosphonull variants (W31 AA), confirming phosphorylation's importance for WRKY31 function .

What are the best practices for using WRKY31 antibodies in chromatin immunoprecipitation (ChIP) assays?

ChIP with WRKY31 antibodies requires optimization for reliable results:

• Chromatin preparation optimization:

  • Test different cross-linking conditions (1-3% formaldehyde for 10-15 minutes)

  • Optimize sonication to achieve 200-500 bp DNA fragments

  • Verify chromatin quality by agarose gel electrophoresis

• Immunoprecipitation conditions:

  • Determine optimal antibody concentration through titration

  • Include appropriate controls:

    • Input chromatin (typically 5-10%)

    • No-antibody control

    • Non-specific IgG control

    • Ideally, chromatin from WRKY31 knockout plants

• Primer design for target genes:

  • Focus on promoter regions containing W-box elements (TTGACC/T) which WRKY31 binds to

  • For OsWRKY31, consider targets like OsGH3.8, OsPIN2, OsWRKY76, OsPR1a, and OsAOS2

  • Include negative control regions without W-box elements

• Sequential ChIP considerations:

  • For studying phosphorylated WRKY31 binding specifically, consider sequential ChIP with WRKY31 antibody followed by phospho-specific antibody

• Data analysis:

  • Normalize to input DNA (percent input method)

  • Compare enrichment at target sites versus non-target regions

  • Use appropriate statistical tests to establish significance

• ChIP-seq considerations:

  • Ensure sufficient sequencing depth (typically 20-30 million reads)

  • Use appropriate peak calling algorithms

  • Perform motif enrichment analysis to confirm W-box enrichment

Remember that phosphorylation enhances OsWRKY31's DNA-binding capability , so consider the phosphorylation status when interpreting ChIP results.

How can I investigate interactions between WRKY31 and MAPK cascade components?

The search results reveal that OsWRKY31 interacts with MAPK cascade components, forming a regulatory module important for stress responses . To investigate these interactions:

• Co-immunoprecipitation (Co-IP) approach:

  • Perform IP with WRKY31 antibodies followed by Western blot for MAPKs (OsMPK3, OsMPK4, OsMPK6) and MAPKKs (OsMKK10-2)

  • Include appropriate controls (IgG, WRKY31 knockout plants)

  • Test interactions under various stress conditions to detect dynamic changes

  • Use phosphatase inhibitors to preserve phosphorylation status

• Reverse Co-IP validation:

  • IP with antibodies against MAPKs/MAPKKs followed by Western blot for WRKY31

  • This confirms bidirectional interaction

• Proximity ligation assay (PLA):

  • Visualize interactions in situ using specific antibodies against WRKY31 and MAPKs

  • Allows subcellular localization of interaction complexes

  • The search results confirm nuclear interactions between OsWRKY31, OsMPK3, and OsMKK10-2

• FRET-FLIM microscopy:

  • If fluorescently tagged proteins are available, use FRET-FLIM to quantify interactions

  • Compare with BiFC results described in the literature

• Kinase-substrate interaction analysis:

  • In vitro kinase assays using purified components

  • Focus on Ser6 and Ser101 phosphorylation sites identified in OsWRKY31

  • Test phosphomimetic and phosphonull variants

The search results show that OsWRKY31, OsMPK3, and OsMKK10-2 form a ternary complex in the nucleus , suggesting coordinated regulation during stress responses.

How can I develop phospho-specific antibodies against WRKY31 phosphorylation sites?

Developing phospho-specific antibodies against WRKY31 requires a methodical approach:

• Phosphopeptide design:

  • Based on the search results, target Ser6 and Ser101 in OsWRKY31

  • Design peptides (10-15 amino acids) with the phosphorylated residue centered

  • Example format: NH2-XXXX[pS]XXXXX-COOH for Ser6 site

  • Include terminal cysteine for carrier protein conjugation if not already present

  • Synthesize both phosphorylated and non-phosphorylated versions of each peptide

• Immunization strategy:

  • Conjugate phosphopeptides to carrier proteins (KLH or BSA)

  • Immunize rabbits using standard protocols

  • Consider using multiple host animals to increase success probability

• Antibody purification process:

  • Perform sequential affinity purification:

    1. First column: non-phosphorylated peptide (to remove antibodies recognizing backbone)

    2. Second column: phosphorylated peptide (to isolate phospho-specific antibodies)

  • Alternatively, use negative selection by passing through non-phospho peptide column first

• Validation experiments:

  • Western blot against recombinant WRKY31 (phosphorylated and non-phosphorylated)

  • Test against phosphomimetic (W31 S6DS101D) and phosphonull (W31 S6AS101A) variants

  • Lambda phosphatase treatment of samples as negative control

  • Test specificity in plant extracts, comparing wild-type and WRKY31 knockout tissues

• Application validation:

  • Monitor WRKY31 phosphorylation during stress responses

  • Compare with functional data showing that phosphomimetic WRKY31 enhances W-box binding activity and disease resistance

The search results demonstrate that phosphorylation at these sites is crucial for OsWRKY31 function in disease resistance , making phospho-specific antibodies valuable research tools.

What methods can I use to study WRKY31's role in transcriptional regulation of stress-responsive genes?

WRKY31 regulates numerous stress-responsive genes. To investigate this regulatory role:

• ChIP-based approaches with WRKY31 antibodies:

  • ChIP-qPCR targeting specific promoters with W-box elements

  • ChIP-seq for genome-wide binding site identification

  • For rice OsWRKY31, target genes include OsGH3.8, OsPIN2, OsWRKY76, OsPR1a, and OsAOS2

  • For wheat TaWRKY31, consider TaSOD(Fe), TaPOD, TaCAT, TaDREB1, TaP5CS, TaNCED1, TaSnRK2, TaPP2C, and TaPYL5

• DNA-protein interaction analysis:

  • EMSA using WRKY31 antibodies for supershift assays

  • DNA affinity purification followed by Western blotting

  • Test binding differences between non-phosphorylated and phosphorylated WRKY31

• Transcriptional activity assays:

  • Dual-luciferase reporter assays with target gene promoters

  • Test activity of wild-type versus phosphomimetic/phosphonull variants

  • The search results show phosphomimetic OsWRKY31 enhances target gene expression

• Chromatin structure analysis:

  • DNase I hypersensitivity assays at WRKY31 target loci

  • ATAC-seq to examine chromatin accessibility changes dependent on WRKY31

  • Histone modification ChIP at target genes in wild-type versus WRKY31 knockout plants

• Integrative analysis:

  • Combine ChIP-seq with RNA-seq data to identify direct targets

  • Compare transcriptomes of wild-type, WRKY31-silenced, and WRKY31-overexpressing plants

  • The search results show that TaWRKY31-silenced plants have reduced expression of stress-responsive genes

• Co-factor identification:

  • IP-mass spectrometry to identify WRKY31-associated transcriptional complexes

  • Re-ChIP to identify co-occupancy of WRKY31 with other transcription factors

The search results indicate that both TaWRKY31 and OsWRKY31 regulate stress-responsive genes, with phosphorylation enhancing OsWRKY31's regulatory activity .

How can WRKY31 antibodies help investigate the relationship between drought tolerance and pathogen resistance pathways?

WRKY31 functions in both drought tolerance (TaWRKY31) and pathogen resistance (OsWRKY31), making it an ideal candidate to study pathway crosstalk:

• Comparative stress response analysis:

  • Monitor WRKY31 protein levels and phosphorylation under drought, pathogen infection, and combined stresses

  • Compare TaWRKY31 (drought-responsive) and OsWRKY31 (pathogen-responsive) regulation patterns

  • Analyze subcellular localization shifts under different stresses

• Pathway component interaction studies:

  • Use WRKY31 antibodies to co-immunoprecipitate interacting partners under different stress conditions

  • Compare interactomes between drought and pathogen stress

  • The search results show OsWRKY31 interacts with MAPK cascade components while TaWRKY31 affects antioxidant enzyme activities

• Hormone signaling integration:

  • Investigate how WRKY31 protein levels respond to different hormones

  • TaWRKY31 expression is induced by ABA but inhibited by ethylene

  • OsWRKY31 functions in disease resistance pathways

  • Analyze protein modification patterns in response to different hormones

• Common target gene regulation:

  • Perform ChIP-seq under different stress conditions to identify stress-specific and common targets

  • Focus on genes involved in both pathways, such as ROS-scavenging enzymes

  • TaWRKY31 silencing decreases SOD, POD, and CAT activities

• ROS regulation analysis:

  • The search results show both TaWRKY31 and OsWRKY31 affect ROS levels

  • Use antibodies to correlate WRKY31 protein levels with ROS accumulation under different stresses

  • Analyze protein modifications in response to oxidative stress

The comparative analysis of TaWRKY31 and OsWRKY31 functions can reveal evolutionary conservation and diversification in WRKY31's role across plant species and stress responses.